A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
Terminated · Phase 3 · NCT04064827
Conditions: Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism (SHPT)
At a glance
- Research payments reported, 2025
- $107,810
- U.S. investigators named
- 7
- Sites paid
- 7
- Planned or actual enrollment
- 2
About the trial
- Sponsor
- AbbVie
- Tested
- Paricalcitol (drug)
- Dates
- Started 2020-09-16; completion 2025-06-09
- Results posted
- Yes
The main objective of this study is to evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution in pediatric participants of ages 0 to 9 years with SHPT associated with stage 5 CKD receiving Peritoneal Dialysis (PD) or Hemodialysis (HD). The 24-week study is divided into two 12-week dosing periods (Dosing Period 1 followed by Dosing Period 2).
From ClinicalTrials.gov, last updated 2026-06-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
AbbVie Inc. reported $107,810 in research payments for this study in 2025 (26 payments).
Products named: Zemplar
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Scott M. Sutherland, MD Pediatric Nephrology · Palo Alto, CA
- Marva M. Moxey-mims, MD Pediatric Nephrology · Washington, DC
- Chryso P. Katsoufis, M.D. Pediatric Nephrology · Miami, FL
- Asifhusen A. Mansuri, M.D. Pediatric Nephrology · Augusta, GA
- Benjamin L. Laskin, M.D. Pediatric Nephrology · Philadelphia, PA
- Marta P. Suarez - Rivera, MD. MPH Pediatric Nephrology · San Juan, PR
- Raoul D. Nelson Pediatric Nephrology · Salt Lake City, UT
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- The Board of Trustees of the Leland $43,794
- Augusta University Research $26,738
- Children's Hospital of Philadelphia, PA $19,310
- University of Puerto Rico Medical Sciences Campus $8,585
- Childrens Research Institute $4,250
- University of Miami $2,950
- University of Utah Hospital and Clinics, UT $2,184
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.